By expenditures
| Name | Title | Type |
|---|---|---|
| Corey Ebert | Director of Finance | Auditee |
| Kevin Kerswick | Partner | Auditee |
| Shane Hacker | TREASURER | Auditee |
| Daniel Sefick | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 339014 | 2024 | 2025-01-21 | Crowe LLP | $16.38M |
| 50997 | 2022 | 2023-03-30 | Cliftonlarsonallen | $17.68M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 339014 | 2024 | 2025-01-21 | 1096264 | 2024-002 | Material Weakness | Yes | I |
| 339014 | 2024 | 2025-01-21 | 1096263 | 2024-002 | Material Weakness | Yes | I |
| 339014 | 2024 | 2025-01-21 | 1096262 | 2024-002 | Material Weakness | Yes | I |
| 339014 | 2024 | 2025-01-21 | 1096261 | 2024-001 | Material Weakness | - | E |
| 339014 | 2024 | 2025-01-21 | 1096260 | 2024-001 | Material Weakness | - | E |
| 339014 | 2024 | 2025-01-21 | 1096259 | 2024-001 | Material Weakness | - | E |
| 339014 | 2024 | 2025-01-21 | 519822 | 2024-002 | Material Weakness | Yes | I |
| 339014 | 2024 | 2025-01-21 | 519821 | 2024-002 | Material Weakness | Yes | I |
| 339014 | 2024 | 2025-01-21 | 519820 | 2024-002 | Material Weakness | Yes | I |
| 339014 | 2024 | 2025-01-21 | 519819 | 2024-001 | Material Weakness | - | E |
| 339014 | 2024 | 2025-01-21 | 519818 | 2024-001 | Material Weakness | - | E |
| 339014 | 2024 | 2025-01-21 | 519817 | 2024-001 | Material Weakness | - | E |
| 50997 | 2022 | 2023-03-30 | 621731 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 621730 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 621729 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 621728 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 621727 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 621726 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 621725 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 621724 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 621723 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 621722 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 621721 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 621720 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 621719 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 621718 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 45289 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 45288 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 45287 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 45286 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 45285 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 45284 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 45283 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 45282 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 45281 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 45280 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 45279 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 45278 | 2022-002 | Significant Deficiency | - | I |
| 50997 | 2022 | 2023-03-30 | 45277 | 2022-003 | Material Weakness | - | I |
| 50997 | 2022 | 2023-03-30 | 45276 | 2022-002 | Significant Deficiency | - | I |